Literature DB >> 1695880

A monoclonal antibody which inhibits the biological activity of rat prolactin, but not prolactin from other species.

J G Scammell1, L B Wear, R Von Haven.   

Abstract

Monoclonal antibodies generated to ovine prolactin were screened for their ability to neutralize the biological activity of prolactin from several species. By Western blot analysis, antibody 6F11 cross-reacted strongly with prolactin in homogenates of anterior pituitary glands from squirrel monkey, sheep and rat. In addition, this antibody (1 micrograms IgG/ml) completely inhibited the lactogenic activity of serum or purified prolactin (0.5 ng/ml) from rat, but not prolactin from any other source, in the Nb2 lymphoma bioassay. 6F11 cross-reacted with purified ovine and rat prolactin by enzyme-linked immunosorbentassay (ELISA) and Western blot analysis with similar affinities, suggesting that the 6F11 epitope was common to these peptides. Another monoclonal antibody (17D9, 35 ng IgG/ml) showed the opposite selectivity, completely inhibiting the activity of 0.3 ng/ml ovine prolactin, but not 0.5 ng/ml rat prolactin, in the Nb2 assay. Thus, we have identified monoclonal antibodies which cross-react with both ovine and rat prolactin, but selectively neutralize the lactogenic activity of prolactin from only one species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695880     DOI: 10.1016/0303-7207(90)90249-8

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  Regulation and distribution of squirrel monkey chorionic gonadotropin and secretogranin II in the pituitary.

Authors:  Audrey A Vasauskas; Tina R Hubler; Christina Mahanic; Susan Gibson; Andrea G Kahn; Jonathan G Scammell
Journal:  Gen Comp Endocrinol       Date:  2010-11-21       Impact factor: 2.822

2.  Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of prolactin and 16K prolactin.

Authors:  F J López-Gómez; L Torner; S Mejía; G M de la Escalera; C Clapp
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.